Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial

Background In this phase I/II trial, we evaluated the safety and effectiveness of pembrolizumab, with or without concurrent radiotherapy (RT), for lung and liver lesions from metastatic non-small cell lung cancer (mNSCLC).Methods Patients with lung or liver lesions amenable to RT plus at least one a...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Chad Tang, Patricia de Groot, James Welsh, Hari Menon, Dawei Chen, Vivek Verma, Mehmet Altan, Kenneth Hess, John V Heymach, Quynh-Nhu Nguyen, Rejani Varghese, Nathan I Comeaux, George Simon, Ferdinandos Skoulidis, Joe Y Chang, Vasiliki Papdimitrakopoulou, Steven H Lin
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMJ Publishing Group 2020-10-01
Rangatū:	Journal for ImmunoTherapy of Cancer
Urunga tuihono:	https://jitc.bmj.com/content/8/2/e001001.full
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!